Industry-academic linkups key to bringing medical innovation to patients, UCSF trio argues

Partnerships with industry are essential for moving academic discoveries to patient bedsides, a high-profile trio of experts with the University of California, San Francisco, argue in the latest issue of Nature Medicine.
Chancellor Susan Desmond-Hellmann — along with professor Clay Johnston, the director of UCSF’s translational science institute, and neurology department chair Stephen Hauser — should know. UCSF has been particularly busy over the past year in constructing deals with Pfizer Inc., Bayer HealthCare and Sanofi-Aventis.